Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: about April:

With your hypothetical, you add: "This would be taking advantage of significant news that was not disclosed to the public - for the company's profit. Insider trading on a "corporate level"."

There's the rub, IMO, and why I strongly believed that PTSC, the corporate entity, could continue to buy. "For the company's profit". Who owns the company? And thus, who would be damaged? People not involved with this stock? Who would benefit? 20,000 Investors in PTSC who have an expectation of benefitting from the investment? Rules of non-disclosure and insider trading talk of "personally benefit", not "corporate benefit" per my recollection.

But, alas, beyond the poorly done response received from Hawk, the company/JT did subsequently come out and say thet PTSC is prohibited from buying. A shame, IMO.

JMHOs,

SGE

Share
New Message
Please login to post a reply